These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2993947)

  • 21. Hyper-reactivity to amphetamine in rats with dopaminergic grafts.
    Herman JP; Choulli K; Le Moal M
    Exp Brain Res; 1985; 60(3):521-6. PubMed ID: 4076374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice.
    Rünkorg K; Värv S; Matsui T; Kõks S; Vasar E
    Neurosci Lett; 2006 Oct; 406(1-2):17-22. PubMed ID: 16916582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral effects of serotonergic and dopaminergic drugs in cats following chronic amphetamine administration.
    Trulson ME; Crisp T
    Eur J Pharmacol; 1984 Apr; 99(4):313-24. PubMed ID: 6734730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Participation of the serotoninergic system of the brain in regulation of emotional reactivity].
    Allikmets LKh; Zharkovskiĭ AM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1975; 25(6):1284-91. PubMed ID: 128934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that serotonin mediates some behavioral effects of amphetamine.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):348-52. PubMed ID: 308099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracerebroventricular cholecystokinin infusions block beta-endorphin-induced disruption of maternal behavior.
    Felicio LF; Mann PE; Bridges RS
    Pharmacol Biochem Behav; 1991 May; 39(1):201-4. PubMed ID: 1924504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood.
    Labonte B; McLaughlin RJ; Dominguez-Lopez S; Bambico FR; Lucchino I; Ochoa-Sanchez R; Leyton M; Gobbi G
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1319-30. PubMed ID: 22053980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of memantine on brain monoaminergic neurotransmission parameters in mice: neurochemical and behavioral study.
    Onogi H; Ishigaki S; Nakagawasai O; Arai-Kato Y; Arai Y; Watanabe H; Miyamoto A; Tan-no K; Tadano T
    Biol Pharm Bull; 2009 May; 32(5):850-5. PubMed ID: 19420753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salmon calcitonin induced head twitch in the rat.
    Gaggi R; De Iasio R
    Jpn J Pharmacol; 1988 May; 47(1):87-90. PubMed ID: 2457726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic melatonin treatment and its precursor L-tryptophan improve the monoaminergic neurotransmission and related behavior in the aged rat brain.
    Esteban S; Garau C; Aparicio S; Moranta D; Barceló P; Fiol MA; Rial R
    J Pineal Res; 2010 Mar; 48(2):170-7. PubMed ID: 20082664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The deafferentation syndrome in the rat: effects of intraventricular neurotensin and cholecystokinin.
    Rossitch E; Ovelmen-Levitt J; Lyerly MA; Nashold BS
    Exp Neurol; 1987 Nov; 98(2):264-75. PubMed ID: 3666078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of serotonergic manipulations on the behavioral sensitization and disinhibition associated with repeated amphetamine treatment.
    Olausson P; Engel JA; Söderpalm B
    Pharmacol Biochem Behav; 2000 May; 66(1):211-20. PubMed ID: 10837863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholecystokinin modulation of apomorphine- or amphetamine-induced stereotypy in rats: opposite effects.
    Tieppo CA; Felicio LF; Nasello AG
    Peptides; 2001 Aug; 22(8):1291-8. PubMed ID: 11457523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex.
    Delion S; Chalon S; Guilloteau D; Besnard JC; Durand G
    J Neurochem; 1996 Apr; 66(4):1582-91. PubMed ID: 8627314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
    Pranzatelli MR; Huang YY; Dollison AM; Stanley M
    Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving effects of long-term growth hormone treatment on monoaminergic neurotransmission and related behavioral tests in aged rats.
    Esteban S; Garau C; Aparicio S; Moranta D; Barceló P; Ramis M; Tresguerres JA; Rial R
    Rejuvenation Res; 2010 Dec; 13(6):707-16. PubMed ID: 21208059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The actions of amphetamine on neurotransmitters: a brief review.
    Moore KE
    Biol Psychiatry; 1977 Jun; 12(3):451-62. PubMed ID: 17437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholecystokinin (CCK): ascension from gut to brain.
    Psychopharmacol Bull; 1983; 19(3):347-63. PubMed ID: 6314422
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of cholecystokinin on dopamine metabolism in the rat brain].
    Kogan BM; Khristoliubova NA; Anokhin KV
    Biull Eksp Biol Med; 1982 Aug; 94(8):42-3. PubMed ID: 7126854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine receptor elevation by cholecystokinin.
    Dumbrille-Ross A; Seeman P
    Peptides; 1984; 5(6):1207-12. PubMed ID: 6531273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.